Bessemer Group
MYOK

Bessemer Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bessemer Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-23,148
Closed -$1.15M – 1929
2018
Q2 		$1.15M Hold
23,148
– – ﹤0.01% 542
2018
Q1 		$1.13M Buy
23,148
+11,870
+105% +$617K ﹤0.01% 556
2017
Q4 		$475K Sell
11,278
-12,800
-53% -$493K ﹤0.01% 824
2017
Q3 		$1.03M Buy
+24,078
New +$768K ﹤0.01% 647
2017
Q2 		– Sell
-10,275
Closed -$135K – 1953
2017
Q1 		$135K Buy
10,275
+1,447
+16% +$18.5K ﹤0.01% 1151
2016
Q4 		$114K Buy
+8,828
New +$136K ﹤0.01% 1203

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Hillhouse Investment Management
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Bessemer Group's MYOK Position: Q3 2018 in Review

Bessemer Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2018, closing a stake of 23,148 shares — an estimated $1.15M sold.

Bessemer Group first reported a position in MYOK in Q4 2016 and held it in 6 quarters. The position peaked at $1.15M in Q2 2018. 125 funds tracked by Wall St. Rank hold MYOK as of Q3 2018.

  • Bessemer Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Bessemer Group sold 23,148 MyoKardia, Inc. Common Stock shares in Q3 2018, an estimated $1.15M.
  • Bessemer Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
  • Bessemer Group's MyoKardia, Inc. Common Stock position peaked at $1.15M in Q2 2018.
  • 125 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2018.

Based on Bessemer Group's 13F filing for Q3 2018, filed 6 Nov 2018.